SAM
TARO

Storebrand Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Storebrand Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-727
Closed -$30.8K – 875
2024
Q1 		$30.8K Hold
727
– – ﹤0.01% 829
2023
Q4 		$30.4K Hold
727
– – ﹤0.01% 831
2023
Q3 		$27.4K Hold
727
– – ﹤0.01% 840
2023
Q2 		$27.6K Hold
727
– – ﹤0.01% 836
2023
Q1 		$17.7K Hold
727
– – ﹤0.01% 841
2022
Q4 		$21.1K Hold
727
– – ﹤0.01% 845
2022
Q3 		$21.8K Hold
727
– – ﹤0.01% 841
2022
Q2 		$26.3K Hold
727
– – ﹤0.01% 842
2022
Q1 		$31.4K Hold
727
– – ﹤0.01% 835
2021
Q4 		$36.4K Hold
727
– – ﹤0.01% 840
2021
Q3 		$46.3K Hold
727
– – ﹤0.01% 828
2021
Q2 		$52.3K Hold
727
– – ﹤0.01% 822
2021
Q1 		$53.6K Hold
727
– – ﹤0.01% 806
2020
Q4 		$53.4K Hold
727
– – ﹤0.01% 810
2020
Q3 		$39.9K Hold
727
– – ﹤0.01% 785
2020
Q2 		$48.3K Hold
727
– – ﹤0.01% 787
2020
Q1 		$44.5K Buy
+727
New +$53.9K ﹤0.01% 770

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Storebrand Asset Management's TARO Position: Q2 2024 in Review

Storebrand Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 727 shares — an estimated $30.8K sold.

Storebrand Asset Management first reported a position in TARO in Q1 2020 and held it in 17 quarters. The position peaked at $53.6K in Q1 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Storebrand Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Storebrand Asset Management sold 727 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $30.8K.
  • Storebrand Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2020 and held it in 17 quarters.
  • Storebrand Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $53.6K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Storebrand Asset Management's 13F filing for Q2 2024, filed 17 Jun 2026.